Healthcare - Biotechnology - NASDAQ - US
$ 1.19
-4.03 %
$ 180 M
Market Cap
-4.58
P/E
Price Target
Average
488.24%
Revenue Forecast
Estimate
19.02%
EBIT
Estimate
--22.21%
Net Income
Estimate
25.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Heron Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HRTX of $7 , with forecasts ranging from a low of $5 to a high of $9 .
HRTX Lowest Price Target
Wall Street Target
5 USD
320.17%
HRTX Average Price Target
Wall Street Target
7 USD
488.24%
HRTX Highest Price Target
Wall Street Target
9 USD
656.30%
REVENUE FORECAST
Revenue Forecast Chart HRTX
EBIT FORECAST
EBIT Forecast Chart HRTX
NET INCOME FORECAST
Net Income Chart HRTX